Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/cpu30877 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Rapid initiation protocol for naltrexone for OUD Alison Knopf The Brown University Child & Adolescent Psychopharmacology Update Your idea of “rapid” may be different from that of the National Institute on Drug Abuse (NIDA), which funded a study showing that it is possible to start patients on injectable, extended‐release naltrexone (trade name Vivitrol) within five to seven days after they stop opioid use — and called that “rapid initiation.” But it's all relative. The standard treatment method was within 10–15 days, according to NIDA. The new finding shortens that painful period. 10.1002/cpu30877 http://onlinelibrary.wiley.com/termsAndConditions#vor